Recent Articles from GlobeNewswire

SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- OpenAI aims to go beyond a conversational assistant with the announcement of a new ChatGPT feature: the ability to recommend products and complete purchases directly within the chat. Anticipating the competitive advantage this innovation brings to retail, one of AI/R Company’s subsidiaries, Avenue Code, today launched a solution that enables retailers to sell their products directly inside ChatGPT, tapping into the full potential of this new sales channel, which already reaches over 700 million weekly users.

WILMINGTON, Del., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the publication of two abstracts with preclinical data on the Company’s JAK2V617F mutant selective inhibitors and CALR-targeted degrader antibody conjugates (DACs) discovery program, both accepted for oral presentation at the American Society of Hematology (ASH) 67th Annual Meeting taking place in Orlando, FL December 6-9, 2025. The abstracts can be found on the ASH 2025 website ASH Annual Meeting & Exposition - Hematology.org.

Report recognizes Cloudera as an ideal choice for organizations that want robust data processing, scalable storage, and persistent data management to power modern business use cases

WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced two poster presentations, including initial data from the RALLY-MF Phase 2 trial of DISC-0974 in anemia of MF, at the upcoming American Society of Hematology (ASH) Annual Meeting, which will be held in Orlando, FL on December 6-9, 2025.

Company brings devices and pricing out of the dark with transparent per-device pricing and autonomous management that replaces expensive, incomplete visibility tools.

High-level spinal cord injury and multiple sclerosis patients can now use the world’s first self-balancing exoskeleton to stand, walk, and regain upright motion safely – helping restore upright mobility

Novel approach designed to address dysregulated RNA splicing events that drive tumor growth and disease progression across multiple hematological malignancies

Former Credit Karma and Square executive brings over 20 years of experience and leadership in driving HR transformation and scaling people functions for high-growth, global organizations

NEWTOWN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced the release of its latest corporate presentation (the “Investor Update”) and the election of Cosmo Jiang, General Partner at Pantera Capital, to the Board of Directors (the “Board”).

New Haven, Ind., Nov. 03, 2025 (GLOBE NEWSWIRE) -- SDI LaFarga COPPERWORKS is proud to announce the promotion of Jerry Evans to President.

New York, Nov. 03, 2025 (GLOBE NEWSWIRE) -- This November, the Muscular Dystrophy Association (MDA) is honoring family caregivers who provide essential support for people living with muscular dystrophy, ALS, and more than 300 related neuromuscular diseases. Throughout the month, MDA will share stories of connection and advocacy that highlight the critical role caregivers play in the lives of the loved ones they support. The organization is also leading efforts on Capitol Hill to advance policies that strengthen caregiver resources and protect access to quality care. Families seeking information and guidance may contact the MDA Resource Center specialists for personalized support and access to care. Donations to support MDA’s mission including resources and community connections for caregivers may be made here.

Gevo expands its carbon business with the groundbreaking delivery, adding a new stream of repeatable revenue now including carbon removal credits (CORCs) in addition to ethanol, protein, vegetable oil, and tax credit sales

Sports.com Content Surpasses 45 Million Views

Abstract available on ASH website

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a moderated digital poster presentation at the upcoming American Heart Association (AHA) Scientific Sessions 2025 to be held November 7-10 in New Orleans, Louisiana.

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, today announced that two abstracts highlighting new clinical and translational data from the Phase 1/2 clinical trial of rondecabtagene autoleucel (ronde-cel, also known as LYL314) for the treatment of aggressive large B-cell lymphoma (LBCL) will be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. Ronde-cel is a next-generation dual-targeting CD19/CD20 CAR T-cell product candidate, currently in pivotal development for the treatment of LBCL, that is designed to increase complete response rates and prolong the duration of response as compared to approved CD19‑targeted CAR T-cell therapies. The FDA has granted ronde-cel Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations for the treatment of relapsed and/or refractory diffuse LBCL in the third- or later-line setting.

Press ReleaseNokia and Rohde & Schwarz collaborate on AI-powered 6G receiver to cut costs, accelerate time to market

Hospital-grade performance meets unmatched comfort: Medela’s new super light weight Magic InBra™ redefines the wearable breast pump experience: no cords and no compromise

Global investment leader brings two decades of expertise to support Octaura’s next phase of innovation

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy data from the BEACON Phase 1/2 clinical trial of BEAM-101 in sickle cell disease (SCD) at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 6-9, 2025, in Orlando. BEAM-101 is an investigational genetically modified ex vivo cell therapy for the treatment of SCD with severe vaso-occlusive crises (VOCs).

STAMFORD, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Finacity Corporation (“Finacity”), a White Oak Global Advisors company, is pleased to announce that it has successfully facilitated a US$20 million 5-year term securitization of a portfolio of consumer loans originated by Baracaf, S.A. de C.V., SOFOM, E.N.R. (“Crediapoyo”). The securitization was done through a Mexican trust with an F/X hedge to match the assets and liabilities. It was funded by a Latin America credit investment firm. Finacity acted as structuring agent and will serve as the Master Servicer responsible for all ongoing program administration and reporting.

Exclusive event to connect senior public and private sector leaders from Dubai with top U.S. investors, financial institutions, and entrepreneurs

Acquisition underscores its momentum and commitment to driving superior digital experiences

Bethesda, MD, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Collage Group, the leading cultural intelligence engine helping brands discover and accelerate growth through culturally-grounded insights and data, announced a planned leadership transition. Co-founder and Chief Executive Officer David Wellisch will assume the new role of Executive Chairman, and Kevin Daly will join Collage Group as Chief Executive Officer, effective today.

Nashville, Tennessee, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Today, “What No One Tells You About Money,” by personal finance expert, bestselling author and co-host of “The Ramsey Show” Jade Warshaw, is now available for presale. Published by Ramsey Press, the book (ISBN: 979-8-887821-37-5) will be released on January 6, 2026, and will retail for $24.99.  

NewGen will issue 500 million shares at US$10 to acquire the mining assets, substantially boosting shareholders’ equity and transforming the merged entity into a multi-billion-dollar conglomerate

RESTON, Va., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Stride, Inc. (NYSE: LRN) (“Stride,” the “Company,” “we,” or “our”), one of the nation’s most successful technology-based education companies, today announced the approval of a stock repurchase program that authorizes the repurchase of up to $500 million of shares of Stride’s common stock until October 31, 2026.

CINCINNATI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Scripps Howard Fund’s ninth annual “If You Give a Child a Book …” campaign will invest a record-breaking $1.8 million during the 2025-2026 academic year, which will provide more than 300,000 books to children at low-income schools across the United States.

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that company management will present at the following two healthcare conferences in November:

SANTA CLARA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Infoblox, the leader in uniting networking, security and cloud with a protective DDI platform, today announced significant new innovations to its Infoblox Universal DDI™ Product Suite, building on strong customer momentum since its launch last year. More than 200 organizations—including Fortune 500 companies across financial services, healthcare, manufacturing and retail—have already adopted Universal DDI to modernize their networks, accelerate operations and improve resiliency across hybrid and multi-cloud environments.

OCALA, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the European Patent Office has officially granted AIM’s European Patent No. 4,096,675, titled “Compositions for Treating LONG COVID,” covering compositions of matter of AIM’s proprietary dsRNAs including, for example, Ampligen® (rintatolimod) for use in the treatment of Long COVID.

Press Release

BARTLETT, Tenn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- SurgePays, Inc. (NASDAQ: SURG)("SurgePays" or the "Company"), a wireless and fintech technology company connecting underserved consumers to essential mobile and financial services, today announced that it plans to host a conference call and report its financial results for the third quarter ended September 30, 2025, on Wednesday, November 12, 2025.

- Oral presentation Sunday, December 7, at ASH 2025 -

OMAHA, Neb., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it will provide a business update and release its third quarter financial results on Monday, November 10, 2025, before market open. An earnings conference webcast will be held at 8:30 AM ET on the same day.

WASHINGTON, DC, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Howard University announced today a transformative $80 million in unrestricted giving from philanthropist MacKenzie Scott, marking one of the largest single contributions in the University’s history. The gifts include $63 million to Howard University and $17 million to the Howard University College of Medicine, both unrestricted, providing the institution with flexible resources to advance strategic priorities and sustain access and opportunities for students who look to Howard as a beacon of excellence, truth and service.

Dr. Bob Akmens & his team have won 80 national Basketball Handicapping Contests

DALLAS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST) (“Strive” or the “Company”) today announced that, subject to market and other conditions, it intends to conduct an initial public offering (the “offering”) registered under the Securities Act of 1933, as amended (the “Securities Act”), of 1,250,000 shares of Strive’s Variable Rate Series A Perpetual Preferred Stock (the “SATA Stock”).

Vilnius, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Hostinger has introduced remixable templates, a new feature in its all-in-one AI partner, Hostinger Horizons, giving creators an effortless way to monetize their ideas online.

Key Insights:

VANCOUVER, Washington, Nov. 03, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including triple-negative breast cancer (TNBC) and metastatic colorectal cancer (mCRC), today announced that it has secured a $30 million funding commitment from Yorkville Advisors Global.

Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance

Dr. Siri Jirapongphan Joins PureCycle Board; Jeffrey R. Fieler Resigns as Director

Combined entity poised to reshape digital payments, asset management, RWA tokenization, and digital media by applying Brag House's proven model to a global stage.

BEIJING, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today announced that representatives from the Chinese Academy of International Trade and Economic Cooperation under the Ministry of Commerce (“CAITEC”) and the Commercial Circulation Promotion Division of the Chaoyang District Bureau of Commerce visited the Company’s Beijing headquarters to conduct a research visit and roundtable discussion focused on e-commerce development planning and high-quality development consulting under China’s Fifteenth Five-Year Plan (2026–2030) for Economic and Social Development of the People's Republic of China (“The Fifteenth Five-Year Plan”).

DUBLIN and BRIDGEWATER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced it will be presenting new findings at the American Heart Association's Scientific Sessions 2025 scheduled for November 7-10 in New Orleans, Louisiana. These new data supported by Amarin will further reinforce the robust efficacy of VASCEPA®/VAZKEPA® (icosapent ethyl) in cardiovascular risk reduction (CVRR) as well as highlight the pleiotropic mechanism of action of Eicosapentaenoic Acid (EPA).

Global evidence and real-world data demonstrate the clinical, operational, and economic impact of AVITA Medical’s RECELL System across wound types and patient populations

SHENZHEN, China, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, recently showcased its flagship platforms, EngageLab and GPTBots.ai, at DXPO Fukuoka 2025 (October 10–11), Japan’s premier Sales & Marketing Digital Transformation Expo held at Marine Messe Fukuoka. The Company demonstrated how its innovative solutions help Japanese enterprises enhance efficiency, customer engagement, and operational excellence.

-- Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval --

WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that management will be participating in the following November 2025 investor conferences.

FORT MYERS, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Alico Inc., (“Alico” or the “Company”) (Nasdaq: ALCO) a Southwest Florida-based agribusiness and land management company with over 125 years of experience, has announced a strategic partnership with the Florida Department of Transportation (“FDOT”) and its construction contractor to design and construct a wildlife underpass as part of a planned expansion of State Road 82 to four lanes in Collier County.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Cost savings, emissions benefits, and transit fleet experience discussed

Signed 20 license agreements with new customers in key growth areas since separationPaid down $11 million of debt in the third quarter, bringing total debt repayment to $312 million since separationFiled patent infringement litigation against AMD

SAN JOSE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations in the semiconductor industry, announced today that it has filed patent infringement lawsuits against Advanced Micro Devices, Inc. (AMD) in the U.S. District Court for the Western District of Texas.

NEEDHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, being held on November 17-20, 2025 in London, United Kingdom.

Acquisition extends Zscaler Zero Trust Exchange with shift-left AI asset discovery, automated red teaming and governance, advancing Zscaler’s AI security leadership

Seasoned development leader to oversee domestic growth and franchise expansion

CORAL GABLES, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich Daly, President and CEO, along with other members of Catalyst's management team, will participate in the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025.

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer (CBO). Dr. Hawryluk will lead Prime’s corporate and business development initiatives, corporate strategy, and alliance management functions, advancing the company’s efforts to expand the reach of Prime Editing through strategic partnerships and collaborations.

LEXINGTON, Ky., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiddleGround Capital (“MiddleGround”), an operationally focused private equity firm that makes control investments in North American and European headquartered middle-market B2B industrial and specialty distribution companies, today announced that it has entered into a definitive agreement to sell its portfolio company Lindsay Precast (“Lindsay” or “the Company”), a leading provider of tailored infrastructure solutions serving the water, utility, data center, renewables, and other high-growth sectors, to TJC, LP (“TJC”), formerly known as The Jordan Company.

EL MONTE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced its inclusion in the TIME | America’s Growth Leaders 2026 list, a ranking honoring companies demonstrating exceptional growth, financial stability, and stock performance.

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate in the following upcoming investor conferences in November:

• Buck Institute’s deployment of Nautilus’ instrument generates tau proteoform data, providing external validation of the company’s next-generation single-molecule proteomics platform • Joint research results show high reproducibility across sites and insight into novel tau biology, signaling a fundamental shift in how proteomics technology can advance human health and longevity • Data presentation at the 2025 HUPO World Congress seminar “Redefining Proteomics with Single-Molecule Iterative Mapping” on November 10

BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the following upcoming investor conferences in November.

Company’s Shares Will Continue to Trade Under Ticker CERO on the OTC Markets

Ghent, Belgium – November 3, 2025 — Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointment of Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer. These appointments strengthen Ardena’s executive leadership team and reflect its continued focus on quality, compliance, and digital integration across its global network.

-2025 is BA’s most significant year yet with new locations and an expanding set of programs to facilitate deal flow, high-power networking, and strategic support for company growth-

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during November:

STMicroelectronics announces status of common share repurchase program

DALIAN, China, Nov. 03, 2025 (GLOBE NEWSWIRE) -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2025 on Monday, November 10, 2025, before the U.S. market opens. The earnings results will be available on the Company's Investor Relations website, and will be filed with the Securities and Exchange Commission on a Form 8-K.

PARSIPPANY, N.J. and TEL AVIV, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of ‘The Other TD,’ a disease education campaign leveraging the broad recognition of football touchdowns to raise awareness and understanding of a lesser-known TD – tardive dyskinesia. The goal of the campaign is to help undiagnosed Americans living with TD, and their care partners, recognize symptoms and take action by having conversations with their healthcare provider. Terrell Davis, known for his iconic initials, “TD,” and for scoring dozens of touchdowns in his career, is partnering with Teva to shine a light on ‘The Other TD’.

SANTA MONICA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a leader in playable media trusted by global brands to reach and activate gaming audiences through playable ads and gamified content, announced today that the Company will post its third quarter 2025 financial results after market close on Thursday, November 13, 2025. A webinar will be held the same day at 5:00 pm Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link.

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

Massachusetts Association of REALTORS® contracts to make FOREWARN services available for its 22,000+ real estate professional members to promote proactive agent safety